Fig. 1From: Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcomaIntratumoral administration of TLR9 agonist in osteosarcoma tumors shows therapeutic efficacy on both treated and distant lesions. A. Graphs show mean volume of mOS69 tumors SD101-treated (left panel) and untreated (right panel). Five animals per group were used. A representative experiment is shown (out of 4 experiments performed). Multiple unpaired t tests, one per time points, were used for statistical analysis. B. Representive histological analysis of tumor lesions in Hematoxylin & eosin. C. Representative images of Masson’s Trichrome staining showing a significant increase in collagen (blue staining). D. Representative images of osteocalcin immunohistochemistry, suggestive of increased tumor cell differentiation and matrix depositionBack to article page